This study therefore raises the possibility of therapeutic intervention to modify intestinal microbiota through gut cleansing antibiotics or pharmacological inhibition of TLR4 signalling in the treatment of patients with acute liver failure. This evidence concerns the gene TLR4 and acute liver failure.